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GENETIC EPIDEMIOLOGY OF SCHEUERMANN'S DISEASE
L. Oei, S. El Saddy, A.A. Makurthou, M.C. Castaño-Betancourt, K.
Estrada, A. Hofman, J.B. van Meurs, A.G. Uitterlinden, E.H. Oei, F.
Rivadeneira. Erasmus MC, Rotterdam, The Netherlands
Purpose: Scheuermann's disease is a form of osteochondrosis of the
spine, characterized by increased posterior rounding of the thoracic
spine in associationwith structural deformity of the vertebral elements.
Although the etiology remains largely unknown, there is evidence that
genetic factors play a role. A Danish twin study has found a heritability
estimate of 74%. Nevertheless, no associated genes have been found to
date. Our aim was to ﬁnd genetic susceptibility factors for Scheuer-
mann's disease.
Methods: The radiographic criteria of Sørensen, Hart and Sachs et al.
were applied to diagnose the Scheuermann's disease cases. Lateral
spine radiographs were available for 2,753 participants from a pop-
ulation-based study (age 45 years and over), of which 111 cases were
diagnosed with Scheuermann's disease. A genome-wide association
study (GWAS) was conducted by applying a logistic model adjusted for
sex and admixture principal components. To facilitate analysis of vari-
ants with lower allele frequency 1000 Genomes imputation (version:
06-2010) was applied.
Results:We found a SNP (minor allele frequency 3%) on chromosome 4
associated at genome-wide signiﬁcant level with radiographically
diagnosed Scheuermann's disease (P¼3.9 *10-8, odds ratio 5.3). The SNP
maps an intron of the tolloid-like-1 gene (TLL1). TLL1 is a protease that
shares structural similarity to BMP1 (Bone morphogenetic protein 1)
and is involved in collagen and chordin synthesis. TLL1 has been
described to induce formation of cartilage in vivo and it has a high
mRNA expression in the femoral growth plate.
Conclusions: This is the ﬁrst GWAS for radiographic Scheuermann's
disease, where we found a SNP associated at genome-wide signiﬁcant
level with Scheuermann's disease mapping to TLL1. Biologically
interesting is that TLL1 is a protease that is involved in collagen and
chordin synthesis and can induce formation of cartilage in vivo.
However, our GWAS had a small sample size because of the relatively
low disease prevalence the population-based study design resulted in
a limited sample size. A replication study is necessary to conﬁrm this
ﬁnding.328
EPIGENETIC REGULATION DURING FETAL FEMUR DEVELOPMENT:
DNA METHYLATION MATTERS
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Sanitaria-Hosp. Clínico, Santiago de Compostela, Spain; x Tohoku Univ.
Sch. of Med., Sendai, Japan; k Stem Cell Unit. Coll. of Med., King Saud
University, Saudi Arabia
Purpose: Epigenetic modiﬁcations are heritable changes in gene
expression without changes in DNA sequence. DNA methylation has
been implicated in the control of several cellular processes including
differentiation, gene regulation, development, genomic imprinting and
X-chromosome inactivation. Methylated cytosine residues at CpG
dinucleotides are commonly associated with gene repression;
conversely, strategic loss of methylation during development could lead
to activation of lineage-speciﬁc genes. To date, there is a paucity of
information regarding the role of DNA methylation in the differentia-
tion of adult human skeletal cells, although some recent studies suggest
that it is involved in the regulation of some bone genes, as well as in
bone cell differentiation. In order to explore a potential link between
DNA methylation changes in gene expression observed during fetal
development, we selected genes that we have previously reported to be
associated with osteoarthritis (OA) and somehow epigenetically
regulated.
Objective: To examine a spectrum of developmental stages of femur
development and the role of DNA methylation therein of genes impli-
cated in bone biology.Methods: Human embryonic stem cells, human fetal bone cells
(HFBCs), adult chondrocytes and STRO-1+ marrow stromal cells from
human bone marrow were collected with informed patient consent
and the permission of the Local Ethics Committee. Genomic DNA
and total RNA were extracted simultaneously. By using pyrosequencing
methodology we analysed the status of methylation of genes
implicated in bone biology; furthermore, we correlated these
methylation levels with gene expression levels using qRT-PCR and
protein distribution during fetal development evaluated using
immunohistochemistry.
Results: We found that during fetal femur development DNA methyl-
ation inversely correlates with expression of physiological genes vital
for bone biology including iNOS and COL9A1 but, not catabolic/paho-
logic genes including MMP13 and IL1B. Furthermore, signiﬁcant
demethylation was evident in the osteocalcin promoter between the
fetal and adult developmental stages. Increased Tet1 expression and
decreased expression of DNA (cytosine-5-)-methyltransferase 1
(DNMT1) in adult chondrocytes compared to HFBCs could contribute to
the loss of methylation observed during fetal development.
Conclusions: HFBCs multipotency conﬁrms these cells to be an ideal
developmental system for investigation of DNA methylation regulation.
These ﬁndings highlight the role of epigenetic regulation, speciﬁcally
DNA methylation, in bone development, informing and opening new
possibilities in development of strategies for bone repair/tissue
engineering.329
EFFECT OF INHIBITORS OF SPECIFIC HISTONE DEACETYLASES (HDAC)
ON CHONDROCYTES
V. Ulici y, E. Zavadak z, R. Tuan y. yUniv. Of Pittsburgh, Pittsburgh, PA, USA;
zChatham Univ., Pittsburgh, PA, USA
Purpose: Osteoarthritis (OA), a multifactorial degenerative joint
disorder and the leading cause of disability in older adults, is caused by
the failure of chondrocytes to maintain the balance between cartilage
matrix synthesis and degradation, resulting in the predominance of
the latter. The role of epigenetic changes in OA has attracted increasing
attention. Higher HDAC expression has been reported in chondrocytes
from OA patients, associated with down-regulation of cartilage-
speciﬁc genes. In a rabbit OA model, pan-HDAC inhibitors, such as
Trichostatin A (TSA), reduced cartilage degradation compared to
control. In general, HDACs are suggested to play a negative role in
cartilage homeostasis and are possibly associated with OA. Previous
studies from our laboratory have shown beneﬁcial effects of pan-HDAC
inhibitors in in-vitro models of OA (supraphysiological mechanical
stimulation and IL1b-treated chondrocytes), such as decreased
expression of inﬂammatory mediators (e.g., inducible nitric oxide
synthase, iNOS) and of a number of matrix metalloproteinases (MMPs:
MMP13 and MMP1), but also some detrimental effects (increased COX-
2 expression and MMP3 expression/secretion). In addition, our
preliminary results have suggested that not all HDACs share the same
mechanism of action in chondrocytes (e.g., HDAC9 decreased after
mechanical stimulation vs other HDACs which were upregulated under
the same conditions). Therefore, we hypothesize that only speciﬁc
HDAC inhibitors (HDI) are effective chondroprotective agents with
minimal negative effects.
Methods: Adult bovine articular chondrocytes were cultured in high
density monolayer cultures (40,000 cells/cm2). The cells were then
treated for 24 h with 4 HDAC speciﬁc inhibitors (HDIs), Entinostat-
MS275 for HDAC1 and 3, Tubostatin A-6, PCI 34015 (PCI)-8 and
Droxinostat-3,6,8), at varying concentrations, and a pan-HDAC inhib-
itor (TSA). A broad range of concentrations was used in order to
analyze the effect of the HDIs on cell proliferation. Selected concen-
trations were used for subsequent experiments. Cellular RNA and
protein were harvested after treatment, followed by SYBR Green real-
time PCR (D-D Ct method) and Western blotting analysis. Culture
medium was also collected for Western blotting analysis. Live/Dead
and MTS assays were performed to assess the cytotoxic effects of the
HDIs.
